Bram Freedman has become the new President and CEO of the JGH Foundation, making him the third generation of his family to include the JGH a key element in his career.
To enable advanced cancer patients to cope with difficulties at the end of life, JGH researchers hope to develop better psychological support through an intervention that helps individuals find meaning in their radically altered lives.
Researchers in the Lady Davis Institute are among investigators from across Canada who will share in new federal funding of $2.5 million for research into various types of dementia, including Alzheimer’s disease.
The largest study ever conducted on the genetics of common, age-related bone disease has resulted in the identification of 153 new gene variants associated with the loss of bone mineral density, the strongest clinical risk factor for osteoporosis and a frequent cause of fractures.
Dr. Pierre Pluye, a Senior Investigator in the Centre for Clinical Epidemiology and Community Studies at the Lady Davis Institute, has been named 2017 Family Medicine Researcher of the Year by the College of Family Physicians of Canada.
A symposium honouring the late Dr. Mark Wainberg on November 2 will become an annual international event on emerging and complex infectious diseases.
Dr. Roderick McInnes, Director of the Lady Davis Institute at the JGH, is being honoured with the 2017 Distinguished Scientist Award by the Canadian Society for Clinical Investigation.
In the ongoing fight against dementia, a research team in the Lady Davis Institute, is looking at electro-magnetic stimulation as a method of targeting the illness through the brain’s electrical impulses.
Although there is little scientific evidence that behaviour can be changed with the help of neurofeedback, some benefits may still result from the technique’s placebo effects.